About Ranexa

Ranexa is indicated for the treatment of chronic angina. Ranexa may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers.

The anti-ischemic and antianginal effects of Ranexa do not depend upon reductions in heart rate or blood pressure.¹ In fact, in controlled clinical studies, patients with chronic angina treated with Ranexa had minimal changes in mean heart rate (< 2 bpm) and systolic blood pressure (< 3 mm Hg).¹ The mechanism of action of ranolazine's antianginal effects has not been determined.